Pharmaceutical companies recall dozens of prescription and over-the-counter (OTC) medications each year. While pharmaceutical companies have a legal obligation to…
Read More →
Most acquisition targets now use AI in ways their own leadership may not fully understand. That creates a new diligence…
Read More →
From AI-powered permitting and evolving federal permitting reforms to the continued resurgence of nuclear energy and new legal battles over…
Read More →
Crypto Companies, Financial Institutions Continue Stablecoin Product Launches – A major U.S. financial services company and payment network recently announced…
Read More →
California’s Senate Bill 574, signed by Governor Gavin Newsom on September 30, 2026, takes effect January 1, 2027. The law bars…
Read More →
Biosimilar Litigations include litigations relating to biosimilar/follow-on products of CDER-listed reference products. Litigations between biosimilar applicants/manufacturers and reference product sponsors…
Read More →
Welcome back to the Class Action & MDL Roundup! This edition covers notable class actions from the second quarter of…
Read More →
Pennsylvania statutorily caps the amount of damages recoverable on tort claims against Commonwealth and local agencies (Section 8528(b) of the…
Read More →
The Seventh Circuit’s July 2026 decision in Franco v. Chobani, LLC is interesting for several reasons for ad law followers…
Read More →
Germany has completed a far-reaching reform of its product liability regime to implement Directive (EU) 2024/2853. The new framework, which…
Read More →